Echo Therapeutics
Biotechnology, Health Care, Medical Device, Therapeutics
Founded in 1989-01-01
Philadelphia, Pennsylvania, United States
For Profit
About Echo Therapeutics
Echo Therapeutics is a medical device company with deep expertise in advanced skin permeation technology. Echo is developing its Symphony® CGM System as a non-invasive, wireless, continuous glucose monitoring system for use in hospital critical care units and for people with diabetes. The Prelude® SkinPrep System, a component of their Symphony CGM System, allows for enhanced skin permeation that will enable extraction of analytes, such as glucose, and transdermal drug delivery.
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: 7 active products
Financial Information
- Estimated Revenue: Less than $1M
- Total Funding: 44701126 USD
- Last Funding: 1787000 USD (Post-IPO Debt)
- Funding Status: IPO
Technology Stack
Echo Therapeutics actively uses 7 products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Medical Device, Therapeutics
Headquarters: Philadelphia, Pennsylvania, United States